These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9495218

  • 1. HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.
    Rey D, Hughes M, Pi JT, Winters M, Merigan TC, Katzenstein DA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar 01; 17(3):203-8. PubMed ID: 9495218
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants.
    Kamkamidze G, Sullivan T, Charbonneau T.
    J Clin Virol; 2001 Aug 01; 22(1):143-8. PubMed ID: 11418362
    [Abstract] [Full Text] [Related]

  • 3. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
    Kuritzkes DR, Sevin A, Young B, Bakhtiari M, Wu H, St Clair M, Connick E, Landay A, Spritzler J, Kessler H, Lederman MM.
    J Infect Dis; 2000 Feb 01; 181(2):491-7. PubMed ID: 10669331
    [Abstract] [Full Text] [Related]

  • 4. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L, Johnson M, Graham N, Shaefer M, St Clair M.
    J Hum Virol; 1999 Feb 01; 2(5):290-5. PubMed ID: 10551735
    [Abstract] [Full Text] [Related]

  • 5. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P.
    J Med Virol; 1999 Dec 01; 59(4):507-11. PubMed ID: 10534734
    [Abstract] [Full Text] [Related]

  • 6. Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.
    Shulman NS, Machekano RA, Shafer RW, Winters MA, Zolopa AR, Liou SH, Hughes M, Katzenstein DA, AIDS Clinical Trials Group 302 Study Team.
    J Acquir Immune Defic Syndr; 2001 Aug 01; 27(4):377-80. PubMed ID: 11468426
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA, Leriche-Guerin K, Regis C, Bordes I, Cotte L, Detmer J, Kolberg J, Ritter J, Trépo C.
    J Med Virol; 2000 Jul 01; 61(3):352-9. PubMed ID: 10861645
    [Abstract] [Full Text] [Related]

  • 8. Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.
    Venturi G, Romano L, Catucci M, Riccio ML, De Milito A, Gonnelli A, Rubino M, Valensin PE, Zazzi M.
    Eur J Clin Microbiol Infect Dis; 1999 Apr 01; 18(4):274-82. PubMed ID: 10385016
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    Merigan TC, Hirsch RL, Fisher AC, Meyerson LA, Goldstein G, Winters MA.
    AIDS; 1996 Feb 01; 10(2):159-65. PubMed ID: 8838703
    [Abstract] [Full Text] [Related]

  • 11. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguiniga E, Halpern J, Merigan TC.
    J Acquir Immune Defic Syndr (1988); 1994 Aug 01; 7(8):832-8. PubMed ID: 7517448
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.
    Lafeuillade A, Poggi C, Hittinger G, Chadapaud S.
    HIV Med; 2001 Oct 01; 2(4):231-5. PubMed ID: 11737402
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
    Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, Gori A, Papagno L, Corvasce S, Mazzucchelli R, Facchi G, Velleca R, Saporetti G, Galli M, Rusconi S, Moroni M.
    Antivir Ther; 2000 Mar 01; 5(1):7-14. PubMed ID: 10846586
    [Abstract] [Full Text] [Related]

  • 14. Selective vertical transmission of HIV-1 antiretroviral resistance mutations.
    Colgrove RC, Pitt J, Chung PH, Welles SL, Japour AJ.
    AIDS; 1998 Dec 03; 12(17):2281-8. PubMed ID: 9863870
    [Abstract] [Full Text] [Related]

  • 15. Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    Ross L, Scarsella A, Raffanti S, Henry K, Becker S, Fisher R, Liao Q, Hirani A, Graham N, St Clair M, Hernandez J, NZT40012 Study Team.
    AIDS Res Hum Retroviruses; 2001 Aug 10; 17(12):1107-15. PubMed ID: 11522180
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408.
    Miller MD, Margot NA, Lamy PD, Fuller MD, Anton KE, Mulato AS, Cherrington JM.
    J Acquir Immune Defic Syndr; 2001 Aug 15; 27(5):450-8. PubMed ID: 11511821
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.